Allogene Therapeutics (ALLO)
Develops off-the-shelf CAR T candidates for cancer and autoimmune disease.
$1.67
vs last close−0.04 (−2.34%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 43 days
EPS estimate
−$0.13
Revenue estimate
$2.5K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.28−$0.28−$0.23−$0.19−$0.17−$0.18−$0.13Pending
Estimate−$0.34−$0.28−$0.28−$0.23−$0.25−$0.19−$0.17−$0.13
Surprise+17.6%0.0%+17.9%+17.4%+32.0%+5.3%+24.1%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$22.0K—————$4.6MPending
Estimate$12.0K$1.7K—$1.8K$2.5K$2.2K$2.5K$2.5K
Surprise+83.3%—————+185,500.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.17 | — | — |
| Sep 2027 | −$0.15 | — | — |
| Jun 2027 | −$0.16 | — | — |
| Mar 2027 | −$0.15 | — | — |
| Dec 2026 | −$0.15 | — | — |
| Nov 2026 | −$0.13 | — | — |
| Aug 2026 | −$0.17 | −$0.13 | +24.1% |
| May 2026 | −$0.19 | −$0.18 | +5.3% |
| Mar 2026 | −$0.25 | −$0.17 | +32.0% |
| Nov 2025 | −$0.23 | −$0.19 | +17.4% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Oct 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.17 | — | — | $1.5M | — | — | — |
| Sep 2027 | −$0.15 | — | — | $6.7K | — | — | — |
| Jun 2027 | −$0.16 | — | — | $5.0K | — | — | — |
| Mar 2027 | −$0.15 | — | — | $5.0K | — | — | — |
| Dec 2026 | −$0.15 | — | — | $2.5K | — | — | — |
| Nov 5, 2026 | −$0.13 | — | — | $2.5K | — | — | — |
| Aug 12, 2026 | −$0.17 | −$0.13 | +24.1% | $2.5K | $4.6M | +185,500.0% | −4.4% |
| May 13, 2026 | −$0.19 | −$0.18 | +5.3% | $2.2K | — | — | −8.2% |
| Mar 12, 2026 | −$0.25 | −$0.17 | +32.0% | $2.5K | — | — | −2.8% |
| Nov 6, 2025 | −$0.23 | −$0.19 | +17.4% | $1.8K | — | — | +12.4% |
| Aug 13, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 13, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 14, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 2, 2023 | |||||||
| May 3, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Nov 2, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 4, 2022 | |||||||
| Feb 23, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 4, 2021 | |||||||
| May 5, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 4, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 6, 2020 | |||||||
| Feb 27, 2020 | |||||||
| Nov 5, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 7, 2019 | |||||||
| Mar 8, 2019 | |||||||
| Nov 22, 2018 | |||||||
| Oct 11, 2018 | |||||||
| Mar 31, 2018 |